BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23901040)

  • 21. Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.
    Vale Rodrigues R; Claro I; Lage P; Rosa I; Ferreira S; Pereira da Silva J; Dias Pereira A
    Int J Colorectal Dis; 2018 Jun; 33(6):695-702. PubMed ID: 29523990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Distribution characteristics and risk factors of colorectal adenomas].
    Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas).
    Jørgensen OD; Kronborg O; Fenger C; Rasmussen M
    Acta Oncol; 2007; 46(3):355-60. PubMed ID: 17450471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.
    Wieszczy P; Kaminski MF; Franczyk R; Loberg M; Kobiela J; Rupinska M; Kocot B; Rupinski M; Holme O; Wojciechowska U; Didkowska J; Ransohoff D; Bretthauer M; Kalager M; Regula J
    Gastroenterology; 2020 Mar; 158(4):875-883.e5. PubMed ID: 31563625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
    Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
    Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal Colonoscopic Surveillance Interval After Normal Baseline Screening Colonoscopy.
    Dong J; Wu M; Miao J; Khan RSU; Zhi T; Zhang T; Li X; Peng Y; Yang G; Nan Q
    Gastroenterol Nurs; 2020; 43(3):225-231. PubMed ID: 32487954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer in patients under close colonoscopic surveillance.
    Robertson DJ; Greenberg ER; Beach M; Sandler RS; Ahnen D; Haile RW; Burke CA; Snover DC; Bresalier RS; McKeown-Eyssen G; Mandel JS; Bond JH; Van Stolk RU; Summers RW; Rothstein R; Church TR; Cole BF; Byers T; Mott L; Baron JA
    Gastroenterology; 2005 Jul; 129(1):34-41. PubMed ID: 16012932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
    Huang EH; Whelan RL; Gleason NR; Maeda JS; Terry MB; Lee SW; Neugut AI; Forde KA
    Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.
    Ballesté B; Bessa X; Piñol V; Castellví-Bel S; Castells A; Alenda C; Paya A; Jover R; Xicola RM; Pons E; Llor X; Cordero C; Fernandez-Bañares F; de Castro L; Reñé JM; Andreu M;
    Dis Colon Rectum; 2007 Jul; 50(7):971-80. PubMed ID: 17468913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors.
    Cottet V; Pariente A; Nalet B; Lafon J; Milan C; Olschwang S; Bonaiti-Pellié C; Faivre J; Bonithon-Kopp C;
    Gastroenterology; 2007 Oct; 133(4):1086-92. PubMed ID: 17919484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
    Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C;
    BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.
    Anderson JC; Baron JA; Ahnen DJ; Barry EL; Bostick RM; Burke CA; Bresalier RS; Church TR; Cole BF; Cruz-Correa M; Kim AS; Mott LA; Sandler RS; Robertson DJ
    Gastroenterology; 2017 Jun; 152(8):1933-1943.e5. PubMed ID: 28219690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
    Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D
    Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer.
    Gaglia P; Atkin WS; Whitelaw S; Talbot IC; Williams CB; Northover JM; Hodgson SV
    Gut; 1995 Mar; 36(3):385-90. PubMed ID: 7698698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer.
    Jablonská M; Rezníková L; Kotrlík J; Svitavský M; Miková M; Tabach J
    Sb Lek; 1995; 96(3):275-82. PubMed ID: 8718819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.
    Wieszczy P; Waldmann E; Løberg M; Regula J; Rupinski M; Bugajski M; Gray K; Kalager M; Ferlitsch M; Kaminski MF; Bretthauer M
    Gastroenterology; 2021 Mar; 160(4):1067-1074.e6. PubMed ID: 33065063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study.
    Cottet V; Jooste V; Fournel I; Bouvier AM; Faivre J; Bonithon-Kopp C
    Gut; 2012 Aug; 61(8):1180-6. PubMed ID: 22110052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermediate-risk patients with three to four small adenomas should be considered low risk for colorectal cancer screening.
    Pérez-Cuadrado-Robles E; Torrella-Cortés E; Bebia-Conesa P; Quesada-Vázquez N; Rodrigo-Agudo JL; Chacón-Martínez S; López-Martín A; Esteban-Delgado P; Pérez-Cuadrado-Martínez E; Pérez-Riquelme F
    Dig Endosc; 2016 May; 28(4):450-455. PubMed ID: 26538148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of adenomas among young individuals at average risk for colorectal cancer.
    de Jong AE; Morreau H; Nagengast FM; Mathus-Vliegen EM; Kleibeuker JH; Griffioen G; Cats A; Vasen HF
    Am J Gastroenterol; 2005 Jan; 100(1):139-43. PubMed ID: 15654793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.